1. Home
  2. PROC

as 11-21-2024 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.

Founded: 1976 Country:
Luxembourg
Luxembourg
Employees: N/A City: N/A
Market Cap: 203.1M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 68.7K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.52 EPS Growth: -12.90
52 Week Low/High: $0.50 - $4.95 Next Earning Date: 11-26-2024
Revenue: $414,096,000 Revenue Growth: -4.80%
Revenue Growth (this year): 5.54% Revenue Growth (next year): 8.54%

PROC Daily Stock ML Predictions

Share on Social Networks: